HCW Biologics HCWB Income Statement (2020-2025)

NASDAQ HCWB
$2.10 -0.20 (-8.70%)
As of: Aug 20, 2026 · 3:59 PM EDT
Income Statement Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
3.12M0.45M1.81M1.34M0.04M0.62M0.85M1.32M1.13M0.62M0.43M0.39M0.01M0.01M0.02M0.03M
Cost of Revenue (Quarter)
1.33M0.29M1.45M1.07M0.03M0.50M0.68M1.07M0.51M0.44M0.34M0.32M0.00M0.01M0.01M0.02M
Gross Profit (Quarter)
1.79M0.17M0.36M0.27M0.01M0.12M0.17M0.25M0.61M0.18M0.09M0.08M0.00M0.00M0.00M0.01M
Operating items
Research & Development (Quarter)
2.33M1.67M2.69M1.48M1.79M1.97M2.65M-5.97M2.26M1.62M1.67M-5.00M2.12M2.03M1.19M-4.95M1.48M1.23M1.40M1.33M
Selling, General & Administrative (Quarter)
1.08M1.08M1.40M1.63M1.88M1.71M1.73M3.01M3.12M1.59M1.51M1.67M1.57M1.59M1.63M2.03M2.23M2.10M1.88M1.51M
Other Operating Expenses (Quarter)
-0.18M516.000.14M0.34M0.38M0.30M0.23M0.09M0.03M0.02M0.01M0.03M0.02M0.02M0.01M0.01M
Operating Expenses (Quarter)
3.41M2.75M4.09M3.11M3.67M3.68M4.38M5.94M5.37M4.63M5.25M11.02M8.11M15.32M3.77M3.23M1.97M3.47M3.30M4.47M
Operating Income (Quarter)
-3.41M-2.75M-4.09M-3.11M-1.88M-3.51M-4.02M-5.67M-5.36M-4.51M-5.08M-10.77M-7.49M-15.14M-3.68M-3.15M-1.97M-3.46M-3.29M-4.46M
EBIT (Quarter)
-3.41M-2.75M-4.09M-3.11M-1.88M-3.51M-4.02M-5.67M-5.36M-4.51M-5.08M-10.77M-7.49M-15.14M-3.68M-3.15M-1.97M-3.46M-3.29M-4.46M
Non-operating items
Non Operating Investment Income (Quarter)
1.75M
Interest & Investment Income (Quarter)
631.00
Non Operating Income (Quarter)
-1.30M
Net income details
EBT (Quarter)
-3.41M-2.79M-4.13M-4.24M-1.89M-3.68M-4.19M-5.76M-5.45M-6.31M-6.88M-10.77M-7.49M-15.30M-3.91M-3.32M-2.22M-3.69M-3.42M-4.67M
Profit After Tax (Quarter)
-2.84M-2.75M-4.09M-3.17M-2.06M-3.51M-3.91M-5.42M-5.07M-4.30M-4.94M-10.68M-7.47M-15.28M-3.90M-3.37M-2.20M-1.93M-4.55M0.72M
Income from Continuing Operations (Quarter)
-3.41M-2.79M-4.13M-4.24M-1.89M-3.68M-4.19M-5.76M-5.45M-6.31M-6.88M-10.77M-7.49M-15.30M-3.91M-3.32M-2.22M-3.69M-3.42M-4.67M
Consolidated Net Income (Quarter)
-3.41M-2.79M-4.13M-4.24M-1.89M-3.68M-4.19M-5.76M-5.45M-6.31M-6.88M-10.77M-7.49M-15.30M-3.91M-3.32M-2.22M-3.69M-3.42M-4.67M
Income towards Parent Company (Quarter)
-3.41M-2.79M-4.13M-4.24M-1.89M-3.68M-4.19M-5.76M-5.45M-6.31M-6.88M-10.77M-7.49M-15.30M-3.91M-3.32M-2.22M-3.69M-3.42M-4.67M
Preferred Dividend Payments (Quarter)
0.48M0.48M
Net Income towards Common Stockholders (Quarter)
-3.32M-3.23M-4.09M-3.17M-2.06M-3.51M-4.19M-5.76M-5.45M-6.31M-6.88M-10.77M-7.49M-15.28M-3.90M-3.37M-2.22M-12.08M-4.55M-3.47M
Additional items
EPS (Basic) (Quarter)
-164.70-157.67-33.23-40.57-13.80-23.52-28.07-38.60-36.48-42.17-45.95-71.92-48.32-96.96-24.76-20.87-0.30-40.72-12.09-9.91
EPS (Diluted) (Quarter)
-157.67-33.23-40.57-13.80-23.52-28.07-38.60-36.48-42.17-45.95-71.92-48.32-96.96-24.76-20.87-0.30-40.72-12.09-9.91
Shares Outstanding (Quarter)
0.02M0.02M0.12M0.08M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.16M0.16M0.16M0.16M7.45M0.30M0.38M0.35M
Shares Outstanding (Diluted) (Quarter)
0.02M0.12M0.08M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.16M0.16M0.16M0.16M7.45M0.30M0.38M0.35M
Shares Outstanding (Entity) (Quarter)
0.02M0.02M0.12M0.08M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.15M0.16M0.16M0.16M0.16M7.49M0.30M0.44M0.35M
EBITDA (Quarter)
-3.41M-2.75M-4.09M-3.11M-1.88M-3.51M-4.02M-5.67M-5.36M-4.51M-5.08M-10.77M-7.49M-15.14M-3.68M-3.15M-1.97M-3.46M-3.29M-4.46M
Interest Expenses (Quarter)
0.04M0.04M1.12M0.01M0.17M0.17M0.09M0.09M1.80M1.80M-0.00M0.16M0.23M0.18M0.26M0.23M0.13M0.21M